This may explain the fact that measurements of KL-6 are not well accepted as diagnostic markers of sarcoidosis and other interstitial lung diseases in most Western countries, in contrast to Japan, where such measurements are routinely used in various clinical settings. The gene discussed is MUC1; the disease is interstitial lung disease.